The 2-day 18th edition of Asia’s largest Life Sciences and Biotechnology convention, BioAsia 2021 kick-started today in the presence of advocates from Life Sciences, Biotechnology, Pharma and Healthcare industries in India and abroad.
The 18th edition of the global forum is being held on 22nd and 23rd February and was inaugurated by the Minister for Industries and Commerce & IT, KT Rama Rao here today. The annual flagship event has taken off with a theme of ‘Moving The Needle’ focusing on COVID-19, Global Health, Pharma and MedTech.
Speaking on the occasion, the Minister expressed happiness at Hyderabad becoming a Vaccine Capital of the world and thanked all the front-line workers including health care and public services, and the Scientists, among others who worked tirelessly during these unprecedented times amongst social and personal challenges. “I take pride in saying that Hyderabad rose to the occasion and made an impact for the world to witness. Our position as the “Vaccine Capital of the World” was further bolstered and it is a matter of pride that the world is looking to India and Hyderabad”, said KTR.
During the inaugural ceremony, along with the Minister, also present in the occasion were Principal Secretary Jayesh Ranjan, Chairman & Managing Director of TSIIC E.V Narasimha Reddy, Director of Telangana Life-sciences & CEO, BioAsia Shakti Nagappan, Chairman of Dr Reddy’s Laboratories Satish Reddy, and Global Head, Novartis Business Services Innovation Naveen Gullapalli and Chairman and Managing Director, Bharat Biotech Dr Krishna Ella.
The organizing committee of BioAsia has bestowed the prestigious Genome Valley Excellence Award 2021 to Bharat BioTech for its breakthrough, pioneering research, development and commercialization of vaccines including COVAXIN, Rabies vaccine, Japanese Encephalitis vaccine, Polio vaccine and Typhoid Conjugate vaccines, among many others that have helped save billions of lives globally. The award was personally received by Dr Krishna Ella and Dr Suchitra Ella.
During the inaugural session, an MoU was signed between the Govt. of Telangana and Cytiva, a global life-science leader to establish Biopharma Scale-up a facility that will be established in Genome Valley to provide professional training, technology evaluation, consultancy services, infrastructure support for process development, and the flexibility to scale up.